The current PE ratio of FLGT cannot be calculated, as the latest EPS of -$5.57 is negative. Fulgent Genetics's last PE ratio on record was 6.26 in December 2022.
The mean historical PE ratio of Fulgent Genetics over the last seven years is 18.88. Looking back at the last seven years, FLGT's PE ratio peaked in the Jun 2020 quarter at 123.08, with a price of $16 and an EPS of $0.13. The Mar 2022 quarter marked the lowest point at 4.05, with a price of $62.41 and an EPS of $15.42.
Maximum annual increase: 7.38% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | 6.26 | 7.38% |
| 2021 | 5.83 | 5.62% |
| 2020 | 5.52 | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
| Stock name | PE ratio | Market cap |
|---|---|---|
| OBIO Orchestra BioMed Holdings Inc | N/A | $174.59M |
| OM Outset Medical Inc | N/A | $208.59M |
| FLGT Fulgent Genetics Inc | N/A | $636.49M |
The current price to earnings ratio of FLGT cannot be determined, as its EPS of -$5.57 is negative.
As an average over the last 3 years, FLGT stock has a PE ratio of 4.81.
As an average over the last 5 years, FLGT stock has a PE ratio of 16.97.
The highest quarterly PE ratio in the last seven years has been 123.08 and it was in the Jun 2020 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.